AKT1 and gastric cancer: Moreover, CLDN4 may inhibit the proliferation, migration, invasion, and tumogenesis of gastric cancer cells by inactivating the PI3K/Akt signaling pathway, and enhancing the sensitivity of gastric cancer cells to chemotherapy [22].